Streetbeat News

Revenues

GTY

Getty Realty (NYSE:GTY) reported Q2 2024 earnings per share of $0.58, beating the analyst estimate of $0.57. The company also reported sales of $49.937 million, surpassing the estimate of $48.781 million and marking an 11.72% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:25 pm

BRKL

Brookline Bancorp (NASDAQ:BRKL) reported Q2 2024 earnings per share (EPS) of $0.19, beating the analyst estimate of $0.18. However, sales of $80.001 million missed the $81.665 million estimate. Both EPS and sales figures are down compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:24 pm

GL

Globe Life (NYSE:GL) reported Q2 2024 adjusted EPS of $2.97, beating the analyst estimate of $2.90. However, sales of $1.440 billion missed the $1.450 billion estimate. Sales increased by 8.60% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:24 pm

MORN

Morningstar reported its Q2 total revenue of $571.9 million and earnings per share (EPS) of $1.60.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:23 pm

NEM

Newmont (NYSE:NEM) reported Q2 2024 adjusted EPS of $0.72, beating the estimate of $0.62. Sales were $4.402 billion, surpassing the $4.116 billion estimate and marking a 64.07% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:23 pm

DRMA

Dermata Therapeutics, Inc. (NASDAQ:DRMA) shares surged over 100% following the announcement that it has enrolled 50% of patients in its Phase 3 STAR-1 clinical trial for a once-weekly topical acne treatment. The company aims to release topline results in Q1 2025. If successful, DMT310 would be the first once-weekly topical product approved for treating moderate-to-severe acne.

Portfolio Pulse from Vaishali Prayag

July 24, 2024 | 8:22 pm

UHS

Universal Health Services (NYSE: UHS) reported strong Q2 2024 earnings, with GAAP EPS of $4.31 beating the $3.32 estimate and sales of $3.907 billion surpassing the $3.864 billion estimate. This represents a 10.12% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:22 pm

BELFA

Bel Fuse (NASDAQ:BELFA) reported Q2 2024 adjusted EPS of $1.46, significantly beating the estimate of $0.87. Sales were $133.205 million, also surpassing the $128.000 million estimate. However, sales decreased by 21.08% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:21 pm

URI

United Rentals has updated its 2024 revenue outlook to a range of $15.05 billion to $15.35 billion, compared to the previous range of $14.95 billion to $15.45 billion. The new outlook is in line with the estimated $15.22 billion.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:21 pm

GSHD

Goosehead Insurance (NASDAQ:GSHD) reported Q2 2024 earnings per share of $0.43, beating the analyst estimate of $0.39. The company also reported sales of $78.088 million, surpassing the $74.241 million estimate. Both earnings and sales showed significant year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 8:19 pm